Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
of Medical Research. The laboratory specialises in single-cell RNA sequencing, spatial transcriptomics and computational pipelines applied to patient biospecimens to understand the complexity of intestinal
-
+ 17% superannuation About the opportunity The Northern Sydney (Arabanoo) Precinct is welcoming applications for a Postdoc Research Associate - Imaging to join their team. The Northern Clinical School is
-
these ideas to areas such as Computer Vision, AI, social network modelling (and related areas) will be a plus: but the candidate must engage with the theoretical aspects of the project. The position requires a
-
of our professional staff cohort, you will be actively involved in working towards our vision of a better world. By supporting the academic endeavour across teaching, research, and the student life
-
languages (C, C++, C#, Python, Matlab), experience with machine learning in robotics or computer vision, a desire to advance resilient, introspective processing architectures in robotics, a desire to work
-
to clearly express ideas and communicate within a team environment the ability to work independently on problems, and motivate junior members of the team a capability to see the bigger picture, and have vision
-
Premier’s Science Fellowship Program, the Population Biology and Genomics Group is a new and rapidly growing research group in the School of Molecular and Life Sciences at Curtin University. To find out more
-
prevention. The successful candidate will join the Wildlife Crime Research Hub and work as part of the ARC Industry Laureate Fellowship program, Combatting Wildlife Crime and Preventing Environmental Harm
-
Professor Jose Polo, Lead of the Cancer Epigenetics Program at the South Australian Immunogenomics Cancer Institute (SAiGENCI) and the Inaugural Director of the Adelaide Centre for Epigenetics (ACE). Together
-
Doctoral Scientist position. This position will report to Professor Jose Polo, Lead of the Cancer Epigenetics Program at the South Australian Immunogenomics Cancer Institute (SAiGENCI) and the Inaugural